pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
LG-631
Glioblastoma Multiforme (GBM)
Lentigen Technology Inc
0
catalysts
Phase 2
LHP-588
Alzheimer's Disease
Lighthouse Pharmaceuticals Inc
0
catalysts
Phase 2
LIOCYXM-004
Hepatocellular Carcinoma
Lion TCR Pte Ltd
0
catalysts
Phase 2
LIS-1
Kidney Transplant Rejection
Xenothera SAS
← prev
page 17 of 50
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
LM-11A31BHS
Alzheimer's Disease
PharmatrophiX Inc
0
catalysts
Phase 2
LM-24C5
Solid Tumor
LaNova Medicines Ltd
0
catalysts
Phase 2
LMP-744
Recurrent Glioblastoma Multiforme (GBM)
Gibson Oncology LLC
0
catalysts
Phase 2
LNTH-2403
Osteosarcoma
$LNTH
Lantheus Holdings, Inc.
0
catalysts
Phase 2
LOAd-703
Pancreatic Ductal Adenocarcinoma
Lokon Pharma AB
0
catalysts
Phase 2
LP-184
Central Nervous System (CNS) Cancer
Starlight Therapeutics Inc
0
catalysts
Phase 2
LPCN-1111
Male Hypogonadism
Verity Pharmaceuticals Inc
0
catalysts
Phase 2
LTI-03
Idiopathic Pulmonary Fibrosis
$RNTX
Rein Therapeutics, Inc.
0
catalysts
Phase 2
LUT-014
Acne And Related Disorders
Lutris Pharma
0
catalysts
Phase 2
LX-1001
Alzheimer's Disease
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
LX-2006
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
LX-2020
Cardiomyopathy
$LXEO
Lexeo Therapeutics, Inc.
0
catalysts
Phase 2
LXE-408
Leishmaniasis
$NVS
NOVARTIS AG
0
catalysts
Phase 2
LXP-109
Non-Small Cell Lung Cancer
LaunXP Biomedical Co Ltd
0
catalysts
Phase 2
LXP-5268
Triple-Negative Breast Cancer (TNBC)
LaunXP Biomedical Co Ltd
0
catalysts
Phase 2
LYGLIV-0001
Liver Diseases
LyGenesis Inc
0
catalysts
Phase 2
LYT-200
Liver Cancer
Gallop Oncology Inc
0
catalysts
Phase 2
Lyophilized Microbiota
Mutational Disorders
Gut-Brain Axis Therapeutics LLC
0
catalysts
Phase 2
M-032
Anaplastic Astrocytoma
UAB Minority Health and Health Equity Research Center
0
catalysts
Phase 2
MAI-001
Depression
Nanjing Mainowei Pharmaceutical Technology Co Ltd.
0
catalysts
Phase 2
MANP
Resistant Hypertension
E-Star BioTech LLC
0
catalysts
Phase 2
MB-105
Cutaneous T-Cell Lymphoma
March Biosciences
0
catalysts
Phase 2
MC-001
Spinal Cord Injury
StemCyte Inc
0
catalysts
Phase 2
MC-232
Hidradenitis Suppurativa
MC2 Therapeutics AS
0
catalysts
Phase 2
MDI-1228
Diabetic Foot Ulcers
Henan Maiyingnuo Pharmaceutical Technology Co Ltd
0
catalysts
Phase 2
MDNA-11
Solid Tumor
$MDNAF
Medicenna Therapeutics Corp.
0
catalysts
